Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0042961 (
volvulus
)
4,305
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The aim of this study was to clarify the role of ganglion cells in the development and recurrence of sigmoid
volvulus
. We analyzed 9 samples obtained from 9 patients who had undergone sigmoidectomy for sigmoid
volvulus
, and, for comparison, 18 samples from 18 patients who had undergone sigmoidectomy or low anterior resection for rectal cancer.
Neuron-specific enolase
was used for immunohistochemical staining to detect ganglion cells, and the number of ganglion cells in 20 contiguous fields was counted at 200? magnification. The average number of ganglion cells per 1000 cm(3) was corrected using the ratio of the circumference of the resected sigmoid colon to the average circumference in the control group. The raw numbers of ganglion cells in the Meissner's and Auerbach's plexuses in the
volvulus
group were significantly lower than those in the non-
volvulus
group (Meissner: p = 0.017, Auerbach: p = 0.007). The circumference of the resected sigmoid colons with
volvulus
was greater than that of those without
volvulus
(p = 0.00013). There was no significant difference in the corrected numbers of ganglion cells in the Meissner's plexus or Auerbach's plexus per 1000 cm(3) between the
volvulus
and non-
volvulus
groups (Meissner: p = 0.410, Auerbach: p = 0.890).Furthermore, there was no significant difference in the corrected numbers of ganglion cells between the revolvulus and non-revolvulus groups. These findings led us to conclude that functional disorder of bowel movement or elongation of the bowel in sigmoid
volvulus
or revolvulus is not related to the number of ganglion cells in Auerbach's or Meissner's plexus.
...
PMID:Role of ganglion cells in sigmoid volvulus. 1559 40